Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2016
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
Steven G DuBois, Araz Marachelian, Elizabeth Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
Ira L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Frontiers in Public Health
|
October 24, 2022
High prevalence of obesity among women in urban Haiti: Findings from a population-based cohort
Eliezer Dade, Miranda Metz, Jean Lookens Pierre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Neuro-Oncology
|
February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
JCO Oncology Advances
|
May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R Reed, Katherine A Janeway, Charles G Minard, et al.
G3 (Bethesda, Md.)
|
January 31, 2022
Transgenic Drosophila lines for LexA-dependent gene and growth regulation
Kathleen R Chang, Deborah D Tsao, Celine Bennett, et al.
JCO Precision Oncology
|
May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome
Xiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2025
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions
Ami V Desai, Aditi Bagchi, Amy E Armstrong, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2016
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
Steven G DuBois, Araz Marachelian, Elizabeth Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
Ira L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Frontiers in Public Health
|
October 24, 2022
High prevalence of obesity among women in urban Haiti: Findings from a population-based cohort
Eliezer Dade, Miranda Metz, Jean Lookens Pierre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Neuro-Oncology
|
February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
JCO Oncology Advances
|
May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R Reed, Katherine A Janeway, Charles G Minard, et al.
G3 (Bethesda, Md.)
|
January 31, 2022
Transgenic Drosophila lines for LexA-dependent gene and growth regulation
Kathleen R Chang, Deborah D Tsao, Celine Bennett, et al.
JCO Precision Oncology
|
May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome
Xiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2025
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions
Ami V Desai, Aditi Bagchi, Amy E Armstrong, et al.
Page
of 19